FDA Clears First New Alzheimer's Disease Drug in Nearly 20 Years
The FDA clears aducanumab targeting amyloid-beta pathology for early Alzheimer's, giving long-awaited optimism to millions of families facing degenerative loss.
The FDA clears aducanumab targeting amyloid-beta pathology for early Alzheimer's, giving long-awaited optimism to millions of families facing degenerative loss.
Educational board empowers teenagers to pick specialized interest tracks directly from school time, allowing earlier career alignment and reduced academic stress.
After raising questions regarding essential health access, Riya Kumari received full graduation funding and healthcare support from a national hygiene company.
Setting a modest standard of public duty, union minister pays out-of-pocket for meal alteration rather than demanding entitlement aboard commercial flight.
After deep family discussions and facing rapid decline, an aging grandfather embraces new cardiac technology to reclaim vitality and shared time with grandchildren.
Reflecting on simple joys after 100°F heatwaves: waking up healthy, morning dog walks, and paying small kindnesses forward in neighborhood communities.